231 related articles for article (PubMed ID: 29105871)
1. Cost-effectiveness of personal tailored risk information and taster sessions to increase the uptake of the NHS stop smoking services: the Start2quit randomized controlled trial.
Wu Q; Gilbert H; Nazareth I; Sutton S; Morris R; Petersen I; Galton S; Parrott S
Addiction; 2018 Apr; 113(4):708-718. PubMed ID: 29105871
[TBL] [Abstract][Full Text] [Related]
2. Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services.
Gilbert H; Sutton S; Morris R; Petersen I; Wu Q; Parrott S; Galton S; Kale D; Magee MS; Gardner L; Nazareth I
Health Technol Assess; 2017 Jan; 21(3):1-206. PubMed ID: 28121288
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the effectiveness of using personal tailored risk information and taster sessions to increase the uptake of smoking cessation services: study protocol for a randomised controlled trial.
Gilbert H; Sutton S; Morris R; Parrot S; Galton S; Nazareth I
Trials; 2012 Oct; 13():195. PubMed ID: 23078797
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial.
Gilbert H; Sutton S; Morris R; Petersen I; Galton S; Wu Q; Parrott S; Nazareth I
Lancet; 2017 Feb; 389(10071):823-833. PubMed ID: 28129989
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial.
Li J; Hajek P; Pesola F; Wu Q; Phillips-Waller A; Przulj D; Myers Smith K; Bisal N; Sasieni P; Dawkins L; Ross L; Goniewicz ML; McRobbie H; Parrott S
Addiction; 2020 Mar; 115(3):507-517. PubMed ID: 31597207
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study.
Li J; Fairhurst C; Peckham E; Bailey D; Arundel C; Hewitt C; Heron P; Crosland S; Parrott S; Gilbody S;
Addiction; 2020 Nov; 115(11):2113-2122. PubMed ID: 32319154
[TBL] [Abstract][Full Text] [Related]
7. Tailored digital behaviour change intervention with e-referral system to increase attendance at NHS stop smoking services (the MyWay project): study protocol for a randomised controlled feasibility trial.
Fulton E; Newby K; Gokal K; Kwah K; Schumacher L; Jackson LJ; Naughton F; Coleman T; Brown K
BMJ Open; 2019 Apr; 9(4):e028721. PubMed ID: 30962245
[TBL] [Abstract][Full Text] [Related]
8. Investigating the cost-effectiveness of three cessation interventions on a national scale using the Economics of Smoking in Pregnancy (ESIP) decision analytical model.
Jones M; Smith M; Lewis S; Parrott S; Coleman T
Addiction; 2022 Nov; 117(11):2907-2917. PubMed ID: 35661312
[TBL] [Abstract][Full Text] [Related]
9. Assessing the fidelity of delivery of an intervention to increase attendance at the English Stop Smoking Services.
Sweeney-Magee M; Kale D; Galton S; Hamill A; Gilbert H
Implement Sci; 2016 Dec; 11(1):166. PubMed ID: 28031035
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Long-term Outcomes of NHS Stop Smoking Services (ELONS): a prospective cohort study.
Dobbie F; Hiscock R; Leonardi-Bee J; Murray S; Shahab L; Aveyard P; Coleman T; McEwen A; McRobbie H; Purves R; Bauld L
Health Technol Assess; 2015 Nov; 19(95):1-156. PubMed ID: 26565129
[TBL] [Abstract][Full Text] [Related]
11. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of computer-tailored smoking cessation advice in primary care: a randomized trial (ESCAPE).
Wu Q; Parrott S; Godfrey C; Gilbert H; Nazareth I; Leurent B; Sutton S; Morris R
Nicotine Tob Res; 2014 Mar; 16(3):270-8. PubMed ID: 24084467
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of smoking cessation services provided by general dental practice, general medical practice, pharmacy and NHS Stop Smoking Services in the North of England.
Csikar JI; Douglas GV; Pavitt S; Hulme C
Community Dent Oral Epidemiol; 2016 Apr; 44(2):119-27. PubMed ID: 26403940
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Facilitated Access to a Self-Management Website, Compared to Usual Care, for Patients With Type 2 Diabetes (HeLP-Diabetes): Randomized Controlled Trial.
Li J; Parrott S; Sweeting M; Farmer A; Ross J; Dack C; Pal K; Yardley L; Barnard M; Hudda M; Alkhaldi G; Murray E
J Med Internet Res; 2018 Jun; 20(6):e201. PubMed ID: 29884608
[TBL] [Abstract][Full Text] [Related]
15. A pilot randomized controlled trial to increase smoking cessation by maintaining National Health Service Stop Smoking Service attendance.
Matcham F; McNally L; Vogt F
Br J Health Psychol; 2014 Nov; 19(4):795-809. PubMed ID: 24289715
[TBL] [Abstract][Full Text] [Related]
16. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
[TBL] [Abstract][Full Text] [Related]
17. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial.
Lennox AS; Osman LM; Reiter E; Robertson R; Friend J; McCann I; Skatun D; Donnan PT
BMJ; 2001 Jun; 322(7299):1396. PubMed ID: 11397745
[TBL] [Abstract][Full Text] [Related]
19. Promoting smoking cessation in Pakistani and Bangladeshi men in the UK: pilot cluster randomised controlled trial of trained community outreach workers.
Begh RA; Aveyard P; Upton P; Bhopal RS; White M; Amos A; Prescott RJ; Bedi R; Barton P; Fletcher M; Gill P; Zaidi Q; Sheikh A
Trials; 2011 Aug; 12():197. PubMed ID: 21854596
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D;
BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
